S5 Ep15: Tarantino Covers HER2-Low Breast Cancer and Antibody-Drug Conjugates

from Treating Together · host Targeted Oncology

In this episode of Emerging Experts, Paolo Tarantino, MD, researcher at the European Institute of Oncology, and clinical research fellow at Dana-Farber Cancer Institute, discusses the latest developments in breast cancer research and treatment, focusing on the evolving understanding of HER2-low breast cancer subtypes and the potential advantages of using antibody-drug conjugates.

Episode metadata supplied by the publisher feed · Published Aug 30, 2024

Embed this episode

Attribution link and audio player

Ready to play

S5 Ep15: Tarantino Covers HER2-Low Breast Cancer and Antibody-Drug Conjugates

0:00 30:43

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Treating Together?

This episode is 30 minutes long.

When was this Treating Together episode published?

This episode was published on August 30, 2024.

Can I download this Treating Together episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!